The Rise, Fall, and Rebirth: BioNTech’s Journey Beyond COVID-19
BioNTech, a key player during the COVID-19 pandemic, faces decreased earnings in a post-COVID world but still surpasses market expectations with €1.08 earnings per share. Revenue declined from €1.479 billion…